Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

175
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
175
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

142
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
142
Human Virome01:26

Human Virome

44
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
44
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

216
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
216
Genomics02:02

Genomics

42.0K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
42.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WIP transcriptional regulators modulate developmental progression in both life cycle phases of a moss.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The I gene defines a dynamic NLR cluster conferring broad potyvirus resistance in common bean.

Nature communications·2026
Same author

Neofunctionalization underlies the evolutionary origin of sclareol biosynthesis in the mint family.

Nature communications·2026
Same author

<i>OAS1</i> and <i>OAS3</i> genetic variants enhance inflammatory responses to SARS-CoV-2.

iScience·2025
Same author

Administration of airborne pathogens in non-human primates.

Inhalation toxicology·2024
Same author

Harbinger transposon insertion in ethylene signaling gene leads to emergence of new sexual forms in cucurbits.

Nature communications·2024

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.9K

Transcriptomics and venomics: implications for medicinal chemistry.

Frédéric Ducancel1, Jordi Durban, Marion Verdenaud

  • 1Department of ImmunoVirology, iMETI/DSV/CEA, Bt 02, 18 rue du Panorama, BP 6, 92265, Fontenay-aux-Roses, France.

Future Medicinal Chemistry
|November 19, 2014
PubMed
Summary

Transcriptomic studies reveal the vast molecular diversity of animal venoms, crucial for discovering new drugs and understanding evolutionary relationships. Technologies have advanced significantly, uncovering complex venomous cocktails.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

10.1K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.9K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

10.1K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.6K

Area of Science:

  • Biochemistry
  • Genomics
  • Pharmacology

Background:

  • Animal venoms possess significant molecular complexity, exceeding initial estimations.
  • Venom gland transcriptomics has evolved over three decades, enhancing molecular exploration.
  • Understanding venom composition is key for drug discovery and phylogenetics.

Purpose of the Study:

  • To review the evolution of transcriptomic technologies for venom gland studies.
  • To highlight the increasing understanding of animal venom complexity.
  • To emphasize the potential of venom compounds in research and development.

Main Methods:

  • Review of historical and current transcriptomic methodologies.
  • Analysis of Next-Generation Sequencing (NGS) strategies.
  • Examination of data from venom gland cell studies.

Main Results:

  • Transcriptomic technologies have progressed from individual cloning to global NGS approaches.
  • Animal venoms are complex bio-optimized cocktails of peptides and proteins.
  • Research interest from academic and industrial sectors is growing.

Conclusions:

  • Advanced transcriptomic studies are vital for characterizing venom diversity.
  • Venom compounds offer a rich source for novel drug candidates.
  • The field is rapidly advancing, driven by technological innovation and interdisciplinary research.